Radiofrequency properties of two different Licox<sup>®</sup> parenchymal brain tissue oxygen probe designs.

29 May 2018

Neuroimaging and continuous multimodality neuromonitoring are both central to the intensive care management of patients with severe traumatic brain injury. Guidelines recommend the use of multimodality monitors including brain tissue oxygen (PbtO2) sensors to assess the adequacy of cerebral oxygen delivery. Devices such as the Lico® sensor (Integra LifeSciences, Plainsboro, NJ) employ a miniature implantable electrochemical cell. Temperature compensation is essential for accurate measurements and the device is now available with an integrated temperature sensor (Model CC1P1). Both devices are rated as MR compatible to 1.5T by the manufacturer.